• Systemic therapy in advanced hepatocellular carcinoma

• Joseph C. Ahn

• Nguyen H. Tran, Yang Ju-Dong

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 516 ~ 519

• Correspondence on Letter regarding ¡°Long-term prognosis and the need for histologic assessment of c...

• Yoo Jeong-Ju

• Kim Sang-Gyune

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 513 ~ 515

• Letter regarding ¡°Long-term prognosis and the need for histologic assessment of chronic hepatitis B...

• Chia-Ming Chu

• Yun-Fan Liaw

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 510 ~ 512

• Next-generation sequencing analysis of hepatitis C virus resistance?associated substitutions in dire...

• Kim Kyung-Ah

• Lee Se-Joon, Park Hye-Jung, Jang Eun-Sun, Lee Youn-Jae, Cho Sung-Bum, Kim Young-Suk, Kim I...

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 496 ~ 509

• Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological...

• Yoo Jeong-Ju

• Park Soo-Young, Moon Ji-Eun, Lee Yu-Rim, Lee Han-Ah, Lee Ji-Eun, Kim Young-Seok, Seo Yeon-...

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 482 ~ 495

• Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under ch...

• Jing Yang

• Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 465 ~ 481

• Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma

• Yi-Te Lee

• Mohammad A. Karim, Hye Chung Kum, Park Sul-Ki, Nicole E. Rich, Mazen Noureddin, Amit G. Singal,...

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 453 ~ 464

• Global burden of primary liver cancer and its association with underlying aetiologies, sociodemograp...

• Choi Sung-Chul

• Kim Beom-Kyung, Lee Seung-Won, Lee Han-Gyeol, Chang Ho-Hyeok, Park Seo-Yeon, Ai Koyanagi, ...

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 433 ~ 452

• Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fa...

• Kathryn Jane Waller

• Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant,&n...

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 417 ~ 432

• The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic ...

• Jin Young-Joo

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 414 ~ 416

• How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

• Song Byeong-Geun

• Sinn Dong-Hyun

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 411 ~ 413

• The effect of moderate alcohol consumption on nonalcoholic fatty liver disease

• Park Ji-Won

• Suk Ki-Tae

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 408 ~ 410

• Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease ? who and how?

• Margaret LP Teng

• Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 404 ~ 407

• Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and fut...

• Kee-Huat Chuah

• Wah-Kheong Chan

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 401 ~ 403

• Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease

• Maamon Basheer

• Mohamed Naffaa, Nimer Assy

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 398 ~ 400

• Non-invasive imaging biomarkers for liver steato- sis in non-alcoholic fatty liver disease: present ...

• Lynna Alnimer

• Mazen Noureddin

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 394 ~ 397

• Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

• Philipp Kasper

• Munevver Demir, Hans-Michael Steffen

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 390 ~ 393

• Implications of comorbidities in nonalcoholic fatty liver disease

• Sherlot Juan Song

• Vincent Wai-Sun Wong

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 384 ~ 389

• Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in l...

• Jang Hee-Joon

• Kim Won

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 381 ~ 383

• Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?

• Chun Ho-Soo

• Lee Min-Jong

• Clinical and Molecular Hepatology   2023  Volume.29  No.2 377 ~ 380